For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Domperidone - Nausea and vomiting (pregnancy)
PAD Profile : Domperidone - Nausea and vomiting (pregnancy) Important
Traffic Light Status
Status 1 of 1.
- Oral suspension
- Tablets
MHRA drug safety update (December 2019- Domperidone for nausea and vomiting: lack of efficacy in children; reminder of contraindications in adults and adolescents : https://www.gov.uk/drug-safety-update/domperidone-for-nausea-and-vomiting-lack-of-efficacy-in-children-reminder-of-contraindications-in-adults-and-adolescents
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Doxylamine succinate/pyridoxine hydrochloride
- Cyclizine hydrochloride
- Promethazine teoclate
- Promethazine hydrochloride
- Prochlorperazine maleate
- Chlorpromazine hydrochloride
- Metoclopramide hydrochloride
- Ondansetron hydrochloride
Other Indications
- Nausea and vomiting
- Lactation stimulation
- Gastro Oesophageal Reflux Disorder (GORD)
- Dyspepsia
- Gastroparesis
- Nausea and vomiting (Parkinson's disease)
- Gastric reflux in Neonates and Children
- Parkinson's Disease (apomorphine pre-treatment)
- Nausea and vomiting (chemotherapy induced)
Additional Documents
Committee Recommendations
The Surrey Heartlands APC agreed a traffic light status and place in therapy for drugs used to treat nausea and vomiting in pregnancy.
Visit the Guideline Profile page for a full list of these drugs and to access the CKS guidelines for nasea & vomiting and pregnancy and the BUMPS website (Best Use of Medicines in Pregnancy).